Conference Coverage

CAR-T cells drive ALL into remission


 

AT ASH 2013

Dr. Lee’s study was supported by the National Cancer Institute and St. Baldrick’s Foundation. He discussed off-label use of CAR-T cells. Dr. Lee reported having no conflicts of interest. Dr. Davila’s study was supported by MSKCC. He reported having no conflicts of interest.

Pages

Recommended Reading

Cord blood transplants improve juvenile myelomonocytic leukemia survival
MDedge Hematology and Oncology
Sulfasalazine may make radiation-induced diarrhea worse
MDedge Hematology and Oncology
Pazopanib shows promise as pediatric sarcoma therapy
MDedge Hematology and Oncology
Sales of leukemia drug suspended because of treatment-associated vascular events
MDedge Hematology and Oncology
Genetic profiling transforms cancer treatment trials
MDedge Hematology and Oncology
Resurrected gemtuzumab shows benefit against pediatric AML
MDedge Hematology and Oncology
Gene therapy for SCID-X1 may successfully reset immune system
MDedge Hematology and Oncology
VIDEO: Idelalisib shows promise in refractory non-Hodgkin lymphoma
MDedge Hematology and Oncology
Sickle cell crises curtailed with experimental cellular adhesion inhibitor
MDedge Hematology and Oncology
VIDEO: What's ahead for chronic myelogenous leukemia?
MDedge Hematology and Oncology